Results 21 to 30 of about 143,184 (363)

TRANSURETHRAL THULIUM:YAG LASER VAPOENUCLEATION IN BENIGN PROSTATIC HYPERPLASIA TREATMENT

Arta Medica, 2021
Objectives. The aim of the study was to analyze evidence based data from existing sources, regarding the role and the efficacy of transurethral Thulium:YAG laser vapoenucleation in benign prostatic hyperplasia treatment. Material and methods.
Alexei Pleșacov, Ivan Vladanov, Vitalii Ghicavîi   +2 more
doaj   +3 more sources

Benign prostatic hyperplasia – what do we know?

BJU International, 2020
To present historical and contemporary hypotheses on the pathogenesis of benign prostatic hyperplasia (BPH), and the potential implications for current medical therapies.
C. Devlin, M. Simms, N. Maitland
semanticscholar   +1 more source

Current Treatment for Benign Prostatic Hyperplasia.

Deutsches Ärzteblatt International, 2020
BACKGROUND Benign prostatic hyperplasia (BPH) is characterized by the occurrence of.disorders of urine storage and bladder emptying. Most men over the age of 60 years are affected to some degree.
A. Miernik, C. Gratzke
semanticscholar   +1 more source

Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: A literature review

International journal of urology, 2021
Benign prostatic hyperplasia is a major disease that affects the quality of life of middle‐aged and older men. Although >70% of men aged >70 years have pathological benign prostatic hyperplasia, its pathogenesis and progression remain unclear.
H. Tsunemori, M. Sugimoto
semanticscholar   +1 more source

The Influencing Role of Diabetes Mellitus and Hypertension in the Establishment of Benign Prostatic Hyperplasia

Journal of Nobel Medical College, 2020
Background: Benign prostatic hyperplasia is regarded as non-malignant growth of prostatic tissueIt is the most common benign tumor in men, and the incidence is age related. In men aged more than 50 years, it is the fourth most prevalent disease.
Ram Sagar Shah, Rabindra Tamang
doaj   +1 more source

Pathology of benign prostatic hyperplasia [PDF]

The Prostate, 2000
Christopher S. Foster
openalex   +4 more sources

Magnitude and associated risk factors of benign prostatic hyperplasia among patients admitted to the surgical department of urology ward in Hawassa University Comprehensive Specialized Hospital, Sidama region, Ethiopia [PDF]

, 2023
Introduction: Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate gland as a result of increased number of stromal and epithelial cells.
Alemayehu, Zinabua, Anegagregn, Amanuel, Aynalem, Shemelis, Belayneh, Mehretu, Eshetu, Samrawit, Melke, Ayantu, Teshale, Michael   +6 more
core   +1 more source

Computer‐aided Evaluation of Polyvalent Medications’ Pharmacological Potential. Multiphytoadaptogen as a Case Study

Molecular Informatics, Volume 42, Issue 1, January 2023., 2023
Abstract Many human diseases including cancer, degenerative and autoimmune disorders, diabetes and others are multifactorial. Pharmaceutical agents acting on a single target do not provide their efficient curation. Multitargeted drugs exhibiting pleiotropic pharmacological effects have certain advantages due to the normalization of the complex ...
O. A. Bocharova, N. S. Ionov, I. V. Kazeev, V. E. Shevchenko, E. V. Bocharov, R. V. Karpova, O. P. Sheychenko, A. A. Aksyonov, S. V. Chulkova, V. G. Kucheryanu, A. V. Revishchin, G. V. Pavlova, V. S. Kosorukov, D. A. Filimonov, A. A. Lagunin, V. B. Matveev, N. V. Pyatigorskaya, I. S. Stilidi, V. V. Poroikov   +18 more
wiley   +1 more source

Role of gangliosides in prostate pathology [PDF]

Romanian Journal of Infectious Diseases, 2016
Molecular pathology of benign prostatic hyperplasia is multifactorial and involves endocrine, biochemical, immunological interactions. The mechanisms involved in the onset and progression of benign prostatic hyperplasia are: infections, 50 years of age ...
Ilinca Nicolae, Corina-Daniela Ene, Simona Roxana Georgescu   +2 more
doaj   +1 more source

Total fluid intake, caffeine, and other bladder irritant avoidance among adults having urinary urgency with and without urgency incontinence: The Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN)

Neurourology and Urodynamics, Volume 42, Issue 1, Page 213-220, January 2023., 2023
Abstract Introduction Caffeine has long been vilified as a cause for urinary urgency incontinence (UUI) along with other potential bladder irritants such as carbonation, alcohol, and acidic juices. The objective of this study was to assess the fluid intake behavior of people with urgency, UUI, and those with lower urinary tract symptoms (LUTS) without ...
Anne P. Cameron, Margaret E. Helmuth, Abigail R. Smith, H. Henry Lai, Cindy L. Amundsen, Ziya Kirkali, Brenda W. Gillespie, Claire C. Yang, J. Quentin Clemens, the LURN Study Group   +9 more
wiley   +1 more source